Financials
- Market Capitalization 2.37 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.02
Fiyat/satışlar oranı
0.98
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1913 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 39.87 USD | +0.53% | +4.59% | +11.71% | +29.03% | 2.32 B USD | ||
| 1920 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 26.01 USD | +0.46% | +0.15% | -3.67% | -35.57% | 2.30 B USD | ||
| 1937 | URGN UroGen Pharma Ltd. - Ordinary Shares | 45.50 USD | -0.96% | -2.94% | +10.71% | +139.47% | 2.22 B USD | ||
| 1950 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.48 USD | -0.36% | -4.19% | +10.23% | +38.14% | 2.19 B USD |